N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
AssigneeMerck & Co., Inc.
InventorsDavid A. Claremon, Nigel Liverton, Harold G. Selnick
Life of this patent
Estimating the term…
Abstract
This invention is concerned with novel compounds represented by structural formula I ##STR1## where R.sup.1 is ##STR2## X and Y are independently hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl; n is 0, 1 or 2; and R.sup.2 is hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl, methyl, or methoxy; as the racemates, mixtures of enantiomers, individual diastereomers or individual enantiomers, and pharmaceutically acceptable crystal forms, salts, or hydrates thereof.
Claims11
A compound of the structural formula I ##STR45## where R.sup.1 is ##STR46## X and Y are independently hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl;
- n is 0, 1 or 2;
- and
- R.sup.2 is hydrogen, fluoro, chloro, bromo, iodo, or trifluoromethyl, methyl, or methoxy;
- as the racemates, mixtures of enantiomers, individual diastereomers or individual enantiomers, and pharmaceutically acceptable crystal forms, salts, or hydrates thereof.
Dependencies are inferred from the claim text.